TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Eating Disorder Examination Interview (EDE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Numerical Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Numerical Comfort Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General Anxiety Disorder-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: UCLA Post-Traumatic Stress Disorder-Reaction Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite mental health measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Musculature Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Presence of Myofascial trigger points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Speed of contraction of the musculature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cmax for Sirolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ctrough for Sirolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ctrough for Everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for Sirolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for Everolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline connectivity with theta wave on EEG at D5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline connectivity with beta wave in EEG at D5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline connectivity with P3 wave EEG at D5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline connectivity with fMRI at D30
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: International Knee Documentation Committee (IKDC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working memory (Digit Span)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attention and processing speed (Trail A and B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patient-reported CIPN symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hyperemic Microvascular Resistance (HMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delta ST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Delta ST Integral
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative measurement at 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative measurement at 4 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative measurement at 6 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative measurement at 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative measurement at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VT Burden (24 hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of post-contrast acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Retinal microvasculature changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Post operative analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First walking time after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Qualification and verification of lung sounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Feasibility of psilocybin treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of subjects with treatment emergent adverse events (TEAEs) in Single Ascending Dose (SAD) compared to placebo
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with clinically significant change from Baseline in vital signs in SAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with laboratory abnormalities in SAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High Sensitivity Troponin (hsTnT) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: thyroid abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Valve-related reintervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time dependent compliance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEEP and time dependent change in dead space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PEEP and time dependent change in shunt fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ICDAS score of the white spot lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optical changes (refractive index) of the white spot lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient perception of the WSL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neuromuscular properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological I
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate to open or laparoscopic approach
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Unanticipated Adverse Device Effect
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of device related or possibly related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Electrophysiological kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBB integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferation of Treg cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of catheter changes
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Knee injury and Osteoarthritis Outcome Score (KOOS)-12
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time for participants to return of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time for participants to first stool passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in amygdala activity indicated by fMRI scan BOLD signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in brain resting state functional network as indicated by fMRI scan connectivity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Adverse Events (AEs) and Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Changes From Baseline in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IBS Symptom severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IBS quality of life scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Anxiety-depression scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ASL Phonological Production Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in BASDAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total frailty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Constricting Response to Pilocarpine 1%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean scores on the Client Satisfaction Questionnaire - 8
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oral Dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mid-Face Volumetric change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion for influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Non-healing status based on change in wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to sustained withdrawal of supplementary oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ICI-induced dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Shortness of breath scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of ruminococcus in the stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Metabolomics results of lesions and atrophic gastritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: VO2 Peak Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fidelity rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Trial retention rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incidence of cystoid macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in exhaled CO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to first protocol defined pulmonary exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Anesthesia related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Surface EMG activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thoracic kyphosis- Lumbal Lordosis angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back Muscle Endurance Test - Sorenson Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of retrieval of the on-demand non-epidural opiate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tryptophan metabolites (Picolinic Acid)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tryptophan metabolites (3-Hydroxykynurenine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tryptophan metabolites (Anthranilic Acid)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tryptophan metabolites (Kynurenine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tryptophan metabolites (Quinolinic Acid)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tryptophan metabolites (Kynurenic Acid)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of securing internship, part-time, or full-time positions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Antibody response to COVID-19 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Undetected minimal residual disease (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: blood oxygen level dependent (BOLD) signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose distribution agreement between virtual and planning CT datasets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric agreement between virtual and planning CT datasets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric agreement between 3D scans taken at different time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to Purchase Sugar-sweetened Beverage vs. Sugar-free Alternative
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical response rate upon re-staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life defined using the LARS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serious AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Participants With AEs That Led to Study Treatment Discontinuations or Modifications
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline salivary cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline psychosocial wellbeing using the Hospital Anxiety and Depression Scale (HADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants Having Established SARS-CoV-2-specific T Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Chest X-ray Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants who Complete Baseline Data Collection and Follow up Data Collection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average Pickleball Session Attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant Evaluation of Feasibility and Acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tumor uptake of 68Ga-PSMA-11
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: rate of seroma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of participants experiencing local reactogenicity symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants experiencing systemic reactogenicity symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants achieving seroprotection at Day 43
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in LA function (strain) by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in LA function (strain) by TTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of TEAEs and TRAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of anal high-grade squamous intraepithelial lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Upper extremity exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant feeding practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Low Anterior Resection Syndrome Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants with confirmed objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure Protocol Fidelity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Phase coordination index (PCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Auditory motor coupling - Resultant Vector Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Auditory motor coupling - Relative phase angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Pneumonitis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of RBCs units per unit of time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Binocular Defocus Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time 0 to time of last quantifiable sample (AUC0-T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gained bone width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Success rate of Ureteral access and Scoping of the stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Genital hygiene behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-care agency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: infantile scale scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mothers' postpartum anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thoracic kyphosis measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar lordosis measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal muscle thickness measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: prevalence of pollen grass sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent change in weight from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quantification of hepatitis B DNA (HBV-DNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of Mtb DNA in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adherence to the intervention (%)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: The number of volunteers recruited to the study (%)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: The number of volunteers retained at the end of the study period (%)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants in the T-cell Lymphoma Master Repository
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Recovery Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Columbia Suicide Severity Rating Scale
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of death and stroke
Endpoint domain: Mortality/survival
Primary endpoint: Vision interference with ability to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in shoulder IR ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in posterior shoulder translation (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in infraspinatus electromyographic activity (%MVIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fracture/osteotomy healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Severity of GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in urine color
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in severity of childhood anxiety disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unanticipated Adverse Device Effects
Endpoint domain: Adverse events/effects
Primary endpoint: HRQoL deterioration free survival
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in log-transformed Lp(a) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Annualized Frequency of Metabolic Decompensation Events (MDEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Survival with organ preservation
Endpoint domain: Mortality/survival